wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35949757-17BFFC9A-F4E3-42CB-B482-1355914CEB0E
Q35949757-17BFFC9A-F4E3-42CB-B482-1355914CEB0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35949757-17BFFC9A-F4E3-42CB-B482-1355914CEB0E
Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
P2860
Q35949757-17BFFC9A-F4E3-42CB-B482-1355914CEB0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35949757-17BFFC9A-F4E3-42CB-B482-1355914CEB0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9659b8f54a9c24847fef61cceb5d036df8cc326
P2860
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.